©Author(s) (or their employer(s)) 2026.
World J Gastroenterol. Mar 14, 2026; 32(10): 116152
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.116152
Published online Mar 14, 2026. doi: 10.3748/wjg.v32.i10.116152
Table 4 Adverse events during percutaneous transhepatic biliary drainage, sinus tract dilation as well as percutaneous transhepatic cholangioscopy-assisted procedures, n (%)
| PTBD (n = 40) | Percutaneous sinus tract dilation (n = 40) | PTCS-assisted anastomotic stricture dilation (n = 31)1 | PTCS-assisted anastomotic recanalization (n = 8) | PTCS-assisted stone therapy (n = 36)2 | |
| Cholangitis | 5 (12.5) | 2 (5.0) | 2 (6.5) | 0 (0.0) | 2 (5.6) |
| Bacteremia | 4 (10.0) | 2 (5.0) | 1 (3.3) | 0 (0.0) | 0 (0.0) |
| Right pleural effusion | 2 (5.0) | 1 (2.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Hemobilia | 0 (0.0) | 1 (2.5)3 | 1 (3.3) | 0 (0.0) | 0 (0.0) |
| Catheter migration | 0 (0.0) | 1 (2.5)4 | 0 (0.0) | 0 (0.0) | 1 (2.8)4 |
| Overall | 11 (27.5) | 7 (17.5) | 4 (12.9) | 0 (0.0) | 3 (8.3) |
- Citation: Ren X, Wang C, Qu YP, Tang XF, Xia T, Lu YX, Sun XM. Percutaneous transhepatic cholangioscopy-assisted procedures for the management of postoperative benign bilioenteric anastomotic strictures with or without biliary stones. World J Gastroenterol 2026; 32(10): 116152
- URL: https://www.wjgnet.com/1007-9327/full/v32/i10/116152.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i10.116152